why choose us

First received: February 13, 2025

Clinical Trial: Efficiency of Botulinum Toxin Type-a in the Management of the Myofascial Pain

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Myofascial Pain - Dysfunction Syndrome of TMJ

Study Type: INTERVENTIONAL


Official Title: Investigation of the Relationship Between Clinical Results of Onabotulinum Toxin a Application and Pain Mediators in the Treatment of Myospasm-Related Masticatory Muscle Disorder

Brief Summary: **Study Title:** Investigation of the Relationship Between Clinical Outcomes and Pain Mediators in the Treatment of Masticatory Muscle Disorders Associated with Myospasm Using Onabotulinum Toxin A**Study Importance:** Temporomandibular disorders (TMD) are a major cause of chronic orofacial pain, affecting 5-12% of the population.Masticatory muscle disorders (MMD) are a common subgroup of TMD, ranging from localized myalgia to fibromyalgia.Myospasm is characterized by sudden pain, malocclusion, and limited jaw…

Read more